Variations in practices and outcomes of neonates with hypoxic ischemic encephalopathy treated with therapeutic hypothermia across tertiary NICUs in Canada

J Perinatol. 2022 Jul;42(7):898-906. doi: 10.1038/s41372-022-01412-7. Epub 2022 May 12.

Abstract

Objective: To characterize variations in practices and outcomes for neonates with hypoxic-ischemic encephalopathy (HIE) treated with therapeutic hypothermia (TH) across Canadian tertiary Neonatal Intensive Care Units (NICUs).

Study design: Retrospective study of neonates admitted for HIE and treated with TH in 24 tertiary NICUs from the Canadian Neonatal Network, 2010-2020. The two primary outcomes of mortality before discharge and MRI-detected brain injury were compared across NICUs using adjusted standardized ratios (SR) with 95% CI.

Results: Of the 3261 neonates that received TH, 367 (11%) died and 1033 (37%) of the 2822 with MRI results had brain injury. Overall, rates varied significantly across NICUs for mortality (range 5-17%) and brain injury (range 28-51%). Significant variations in use of inotropes, inhaled nitric oxide, blood products, and feeding during TH were identified (p values < 0.01).

Conclusion: Significant variations exist in practices and outcomes of HIE neonates treated with hypothermia across Canada.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain Injuries* / therapy
  • Canada
  • Humans
  • Hypothermia, Induced*
  • Hypoxia-Ischemia, Brain* / diagnostic imaging
  • Hypoxia-Ischemia, Brain* / therapy
  • Infant, Newborn
  • Intensive Care Units, Neonatal
  • Retrospective Studies